Log in to save to my catalogue

Ticagrelor reversal: in vitro assessment of four haemostatic agents

Ticagrelor reversal: in vitro assessment of four haemostatic agents

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1865531834

Ticagrelor reversal: in vitro assessment of four haemostatic agents

About this item

Full title

Ticagrelor reversal: in vitro assessment of four haemostatic agents

Publisher

England: BMJ Publishing Group LTD

Journal title

Journal of clinical pathology, 2017-09, Vol.70 (9), p.733-739

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

AimManagement of ticagrelor-induced bleeding is challenging as platelet transfusion is ineffective. An effective strategy is needed. This study aimed to investigate in vitro the efficacy of four haemostatic drugs (HDs), namely recombinant activated factor VII (rFVIIa), fibrinogen concentrate (Fib), tranexamic acid (TXA) and factor XIII concentrate...

Alternative Titles

Full title

Ticagrelor reversal: in vitro assessment of four haemostatic agents

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1865531834

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1865531834

Other Identifiers

ISSN

0021-9746

E-ISSN

1472-4146

DOI

10.1136/jclinpath-2016-204117

How to access this item